High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.

K. L. Davis,E. Gray,P. Moore,J. Decker,A. Salomon,D. Montefiori,B. Graham,M. Keefer,A. Pinter,L. Morris,B. Hahn,G. Shaw
DOI: https://doi.org/10.1016/j.virol.2009.02.022
IF: 3.513
2009-05-10
Virology
Abstract:
What problem does this paper attempt to address?